To further analyze ERα signaling dynamics during therapy-mediated immune pressure, we evaluated the estrogen response using single-cell RNA-Seq available data from patients with HR+ BC before (pretreatment) and during (on-treatment) therapy consisting of 1 cycle of anti–PD-1 treatment (42). This evidence concerns the gene ESR1 and breast cancer.